130 related articles for article (PubMed ID: 31075239)
1. Activation of G-protein-coupled bile acid receptor Gpbar1 (TGR5) inhibits degradation of type II collagen and aggrecan in human chondrocytes.
Zhuo W; Li B; Zhang D
Eur J Pharmacol; 2019 Aug; 856():172387. PubMed ID: 31075239
[TBL] [Abstract][Full Text] [Related]
2. The protective effects of dulaglutide against advanced glycation end products (AGEs)-induced degradation of type Ⅱ collagen and aggrecan in human SW1353 chondrocytes.
Li H; Chen J; Li B; Fang X
Chem Biol Interact; 2020 May; 322():108968. PubMed ID: 32004530
[TBL] [Abstract][Full Text] [Related]
3. Salicin inhibits AGE-induced degradation of type II collagen and aggrecan in human SW1353 chondrocytes: therapeutic potential in osteoarthritis.
Gao F; Zhang S
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1043-1049. PubMed ID: 30942091
[TBL] [Abstract][Full Text] [Related]
4. Activation of GPR40 Suppresses AGE-Induced Reduction of Type II Collagen and Aggrecan in Human SW1353 Chondrocytes.
Gu J; Lin H; Zhang Y; Xu T; Wang T; Xue X; Zhang W; Liu H
Drug Des Devel Ther; 2020; 14():2371-2379. PubMed ID: 32606604
[TBL] [Abstract][Full Text] [Related]
5. Saxagliptin suppresses degradation of type II collagen and aggrecan in primary human chondrocytes: a therapeutic implication in osteoarthritis.
Hu N; Gong X; Yin S; Li Q; Chen H; Li Y; Li F; Qing L; Yang J; Zhu S; Wang J; Li J
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3239-3245. PubMed ID: 31364869
[TBL] [Abstract][Full Text] [Related]
6. Agonism of GPR39 displays protective effects against advanced glycation end-product (AGE)-induced degradation of extracellular matrix in human SW1353 cells.
Shan W; Qi J; Li C; Nie X
Arch Biochem Biophys; 2019 Nov; 677():108164. PubMed ID: 31678046
[TBL] [Abstract][Full Text] [Related]
7. Ivabradine abrogates TNF-α-induced degradation of articular cartilage matrix.
Xiang X; Zhou Y; Sun H; Tan S; Lu Z; Huang L; Wang W
Int Immunopharmacol; 2019 Jan; 66():347-353. PubMed ID: 30521963
[TBL] [Abstract][Full Text] [Related]
8. Vildagliptin reduced extracellular matrix degradation in human primary chondrocytes.
Wang Z; Xu M; Bai J; Ge G; Guo X; Yu B; Xiao L; Geng D; Hao Y
Eur J Pharmacol; 2019 Feb; 844():49-55. PubMed ID: 30452909
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein-7 antagonizes tumor necrosis factor-α-induced activation of nuclear factor κB and up-regulation of the ADAMTS, leading to decreased degradation of disc matrix macromolecules aggrecan and collagen II.
Wang Z; Hutton WC; Yoon ST
Spine J; 2014 Mar; 14(3):505-12. PubMed ID: 24176808
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of alogliptin against TNF-α-induced degradation of extracellular matrix in human chondrocytes.
Zhang P; Chen Y; Zhao H; Du H
Int Immunopharmacol; 2019 Mar; 68():179-184. PubMed ID: 30654307
[TBL] [Abstract][Full Text] [Related]
11. Lixisenatide attenuates advanced glycation end products (AGEs)-induced degradation of extracellular matrix in human primary chondrocytes.
Li X; Jia F; Zhu Z; Huang L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1256-1264. PubMed ID: 30942623
[TBL] [Abstract][Full Text] [Related]
12. Roxatidine Attenuates Degradation of Extracellular Matrix.
Ze R; Wang S; Xie M; Zhang B; Tang X; Li J
Biomed Pharmacother; 2017 Nov; 95():1156-1160. PubMed ID: 28926925
[TBL] [Abstract][Full Text] [Related]
13. Sodium butyrate abolishes the degradation of type II collagen in human chondrocytes.
Bo W; Zhou J; Wang K
Biomed Pharmacother; 2018 Jun; 102():1099-1104. PubMed ID: 29710527
[TBL] [Abstract][Full Text] [Related]
14. Activation of the bile acid receptor GPBAR1 (TGR5) ameliorates interleukin-1β (IL-1β)- induced chondrocytes senescence.
Huang H; Lei H; Yang F; Fan X; Dang Q; Li Y
Biomed Pharmacother; 2018 Oct; 106():1713-1719. PubMed ID: 30119246
[TBL] [Abstract][Full Text] [Related]
15. Chrysin Attenuates IL-1β-Induced Expression of Inflammatory Mediators by Suppressing NF-κB in Human Osteoarthritis Chondrocytes.
Zheng W; Tao Z; Cai L; Chen C; Zhang C; Wang Q; Ying X; Hu W; Chen H
Inflammation; 2017 Aug; 40(4):1143-1154. PubMed ID: 28364187
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end products cause collagen II reduction by activating Janus kinase/signal transducer and activator of transcription 3 pathway in porcine chondrocytes.
Huang CY; Lai KY; Hung LF; Wu WL; Liu FC; Ho LJ
Rheumatology (Oxford); 2011 Aug; 50(8):1379-89. PubMed ID: 21482542
[TBL] [Abstract][Full Text] [Related]
17. Azilsartan prevented AGE-induced inflammatory response and degradation of aggrecan in human chondrocytes through inhibition of Sox4.
Lei J; He M; Xu L; He C; Li J; Wang W
J Biochem Mol Toxicol; 2021 Aug; 35(8):e22827. PubMed ID: 34051020
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of gemigliptin against type II collagen degradation in human chondrocytes.
Mohetaer M; Li G; Wang Y; Cao L
Biomed Pharmacother; 2018 Aug; 104():590-594. PubMed ID: 29803171
[TBL] [Abstract][Full Text] [Related]
19. Shikimic acid prevents cartilage matrix destruction in human chondrocytes.
Guo X; Wang L; Xu M; Bai J; Shen J; Yu B; Liu Y; Sun H; Hao Y; Geng D
Int Immunopharmacol; 2018 Oct; 63():155-160. PubMed ID: 30096598
[TBL] [Abstract][Full Text] [Related]
20. Cabozantinib prevents AGEs-induced degradation of type 2 collagen and aggrecan in human chondrocytes.
Dong Y; Lin L; Ji Y; Cheng X; Zhang Z
Aging (Albany NY); 2023 Dec; 15(23):13646-13654. PubMed ID: 38059882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
